Abstract
Background
Hemorrhoidectomy is the standard procedure for treating high-grade hemorrhoids. However, postoperative pain usually causes patients to delay or refuse surgical treatment. Because maximal resting pressure in the internal anal sphincter plays a major role in post-hemorrhoidectomy pain, Botulinum toxin injections have been proposed to reduce it. However, the optimal timing of Botulinum toxin injections is still unclear. The aim of the present study was to compare the effectiveness of early and intraoperative Botulinum toxin injections for postoperative pain control.
Methods
In this pilot study, we enrolled patients who had grade III or IV hemorrhoids and underwent Ferguson hemorrhoidectomy at a single tertiary care center from October 1, 2018 to November 30, 2020. The experimental group received 50 U Botulinum toxin injections to the internal anal sphincter 1 week before the operation, and the control group received injections intraoperatively. The primary endpoint was the daily maximal and resting visual analogue scale (VAS) score recorded from postoperative days 0–6. The secondary endpoints were analgesia requirements, number of bowel movements per day, healing time, and postoperative length of stay. Power of the daily resting VAS score is at least 93%, but the power of the daily maximal VAS is a little lower (71%) (calculated by G*Power 3.1.9.2).
Results
Sixty-two patients (male: female = 27:35; mean age = 47.6 ± 13.1 years) were randomized to the experimental group (n = 31) or control group (n = 31). The experimental group (n = 31) showed significantly shorter postoperative hospital stay than the controls (n = 31; p = 0.019). A generalized estimating equations model revealed that the group that received Botulinum toxin yielded a significantly lower maximal (OR 0.4, 95% CI 0.2–1.0, p = 0.041) and resting (OR 0.4, 95% CI 0.2–0.7, p < 0.001) VAS compared to controls at all time points. The Botulinum toxin group also had significantly less resting pain from postoperative days 1–5, and lower maximal subjective pain scores on postoperative days 1 (p = 0.024) and 4 (p = 0.044). Similar trends were observed on other days.
Conclusions
Early Botulinum toxin injection produced shorter hospital stays, and less reported pain after hemorrhoidectomy than intraoperative injections, especially for pain at rest.
Trial registration
Identifier: NCT04485780 on ClinicalTrials.gov (retrospectively registered).
Similar content being viewed by others
References
Patti R, Almasio PL, Arcara M, Sammartano S, Romano P, Fede C et al (2006) Botulinum toxin vs. topical glyceryl trinitrate ointment for pain control in patients undergoing hemorrhoidectomy: a randomized trial. Dis Colon Rectum 49:1741–1748
Davies J, Duffy D, Boyt N, Aghahoseini A, Alexander D, Leveson S (2003) Botulinum toxin (botox) reduces pain after hemorrhoidectomy: results of a double-blind, randomized study. Dis Colon Rectum 46:1097–1102
Uzzaman MM, Siddiqui MRS (2011) A brief literature review on the management of post-haemorrhoidectomy pain. Surg Tech Dev 1:e32
Patti R, Almasio PL, Muggeo VM, Buscemi S, Arcara M, Matranga S et al (2005) Improvement of wound healing after hemorrhoidectomy: a double-blind, randomized study of botulinum toxin injection. Dis Colon Rectum 48:2173–2179
Jones OM, Brading AF, Mortensen NJ (2004) Mechanism of action of botulinum toxin on the internal anal sphincter. Br J Surg 91:224–228
Hallett M (1999) One man’s poison–clinical applications of botulinum toxin. N Engl J Med 341:118–120
Sajid MS, Hunte S, Hippolyte S, Kiri VA, Maringe C, Baig MK (2008) Comparison of surgical vs chemical sphincterotomy using botulinum toxin for the treatment of chronic anal fissure: a meta-analysis. Colorectal Dis 10:547–552
Siddiqui MRS, Abraham-Igwe C, Shangumanandan A, Grassi V, Swift I, Abulafi AM (2011) A literature review on the role of chemical sphincterotomy after Milligan-Morgan hemorrhoidectomy. Int J Colorectal Dis 26:685–692
Ho YH, Seow-Choen F, Tan M, Leong AF (1997) Randomized controlled trial of open and closed haemorrhoidectomy. Br J Surg 84:1729–1730
Galizia G, Lieto E, Imperatore V, Pelosio L, Castellano P (2000) The usefulness of lateral internal sphincterotomy combined with hemorrhoidectomy in the treatment of hemorrhoids: a randomized prospective study. G Chir 21:127–134
Kanellos I, Zacharakis E, Christoforidis E, Angelopoulos S, Kanellos D, Pramateftakis MG et al (2005) Usefulness of lateral internal sphincterotomy in reducing postoperative pain after open hemorrhoidectomy. World J Surg 29:464–468
Wang WG, Lu WZ, Yang CM, Yu KQ, He HB (2018) Effect of lateral internal sphincterotomy in patients undergoing excisional hemorrhoidectomy. Medicine (Baltimore) 97:e11820
Emile SH, Youssef M, Elfeki H, Thabet W, El-Hamed TM, Farid M (2016) Literature review of the role of lateral internal sphincterotomy (LIS) when combined with excisional hemorrhoidectomy. Int J Colorectal Dis 31:1261–1272
McLeod RS, Evans J (2002) Symptomatic care and nitroglycerin in the management of anal fissure. J Gastrointest Surg 6:278–280
Witte ME, Klaase JM (2007) Botulinum toxin A injection in ISDN ointment-resistant chronic anal fissures. Dig Surg 24:197–201
Sajid MS, Whitehouse PA, Sains P, Baig MK (2013) Systematic review of the use of topical diltiazem compared with glyceryltrinitrate for the nonoperative management of chronic anal fissure. Colorectal Dis 15:19–26
Sahebally SM, Ahmed K, Cerneveciute R, Iqbal A, Walsh SR, Joyce MR (2017) Oral versus topical calcium channel blockers for chronic anal fissure-a systematic review and meta-analysis of randomized controlled trials. Int J Surg 44:87–93
Nelson RL, Thomas K, Morgan J, Jones A (2012) Non surgical therapy for anal fissure. Cochrane Database Syst Rev 2012:CD003431
Runfola M, Di Mugno M, Balletta A, Magalini SC, Gui D (2006) Antinociceptive effect of botulinum toxin: an added value to chemical sphincterotomy in anal fissure? Dis Colon Rectum 49:1078–1079
Sirikurnpiboon S, Jivapaisarnpong P (2020) Botulinum toxin injection for analgesic effect after hemorrhoidectomy: a randomized control trial. J Anus Rectum Colon 4:186–192
Brisinda G, Cadeddu F, Brandara F, Marniga G, Maria G (2007) Randomized clinical trial comparing botulinum toxin injections with 0.2 per cent nitroglycerin ointment for chronic anal fissure. Br J Surg 94:162–167
Bobkiewicz A, Francuzik W, Krokowicz L, Studniarek A, Ledwosinski W, Paszkowski J et al (2016) Botulinum toxin injection for treatment of chronic anal fissure: is there any dose-dependent efficiency? A meta-analysis. World J Surg 40:3064–3072
Lin JX, Krishna S, Su’a B, Hill AG (2016) Optimal dosing of botulinum toxin for treatment of chronic anal fissure: a systematic review and meta-analysis. Dis Colon Rectum 59:886–894
Singh B, Box B, Lindsey I, George B, Mortensen N, Cunningham C (2009) Botulinum toxin reduces anal spasm but has no effect on pain after haemorrhoidectomy. Colorectal Dis 11:203–207
Minguez M, Melo F, Espi A, Garcia-Granero E, Mora F, Lledo S et al (1999) Therapeutic effects of different doses of botulinum toxin in chronic anal fissure. Dis Colon Rectum 42:1016–1021
Acknowledgements
We would like to acknowledge the data collection and patient treatment provided by the members of the Division of Colon and Rectal Surgery, Department of Surgery.
Funding
None.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare no conflict of interests.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Cheng, YC., Beh, J.YM., Wu, PH. et al. Early botulinum toxin injection reduces pain after hemorrhoidectomy: a pilot study. Tech Coloproctol 26, 53–60 (2022). https://doi.org/10.1007/s10151-021-02542-4
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10151-021-02542-4